바로가기메뉴

본문 바로가기 주메뉴 바로가기

logo

Low-Dose Off-Label Use of Phentermine/Topiramate in the Individual with Morbid Obesity and Postoperative Hypothyroidism

Archives of Obesity and Metabolism / Archives of Obesity and Metabolism, (P)2951-0333; (E)2951-0597
2022, v.1 no.1, pp.43-45
https://doi.org/10.23137/AOM2022.01.CR0002
Jung Ha Park (Department of Family Medicine, Jeju National University Hospital, Jeju, Korea)
  • Downloaded
  • Viewed

Abstract

Intensive lifestyle modifications and anti-obesity medications are essential for obesity treatment. Antiobesity medications should be selected according to the patient’s comorbidities, symptoms, and preferences. This case report describes the treatment of a morbidly obese patient with a history of depression, who complained of tingling and numbness after total thyroidectomy for papillary thyroid cancer. Very low-dose controlled-release phentermine/topiramate was prescribed and intensive lifestyle modifications were encouraged. As a result, the patient effectively lost weight and reached a near-normal weight without adverse drug effects. This implies that even an off-label anti-obesity medication low dose may be better for some patients, and the most important factor in obesity treatment is patient-tailored treatment.

keywords
Obesity, Anti-obesity agents, Comorbidity, Case reports

Archives of Obesity and Metabolism